Olayioye MA - Search Results

1

Loss of STARD10 expression identifies a group of poor prognosis breast cancers independent of HER2/Neu and triple negative status.

Murphy NC, Biankin AV, Millar EK, McNeil CM, O'Toole SA, Segara D, Crea P, Olayioye MA, Lee CS, Fox SB, Morey AL, Christie M, Musgrove EA, Daly RJ, Lindeman GJ, Henshall SM, Visvader JE, Sutherland RL. Murphy NC, et al. Among authors: olayioye ma. Int J Cancer. 2010 Mar 15;126(6):1445-53. doi: 10.1002/ijc.24826. Int J Cancer. 2010. PMID: 19676041

2

The phosphoprotein StarD10 is overexpressed in breast cancer and cooperates with ErbB receptors in cellular transformation.

Olayioye MA, Hoffmann P, Pomorski T, Armes J, Simpson RJ, Kemp BE, Lindeman GJ, Visvader JE. Olayioye MA, et al. Cancer Res. 2004 May 15;64(10):3538-44. doi: 10.1158/0008-5472.CAN-03-3731. Cancer Res. 2004. PMID: 15150109

3

StarD10, a START domain protein overexpressed in breast cancer, functions as a phospholipid transfer protein.

Olayioye MA, Vehring S, Müller P, Herrmann A, Schiller J, Thiele C, Lindeman GJ, Visvader JE, Pomorski T. Olayioye MA, et al. J Biol Chem. 2005 Jul 22;280(29):27436-42. doi: 10.1074/jbc.M413330200. Epub 2005 May 23. J Biol Chem. 2005. PMID: 15911624 Free article.

4

Breast cancer protein StarD10 identified by three-dimensional separation using free-flow electrophoresis, reversed-phase high-performance liquid chromatography, and sodium dodecyl sulfate-polyacrylamide gel electrophoresis.

Hoffmann P, Olayioye MA, Moritz RL, Lindeman GJ, Visvader JE, Simpson RJ, Kemp BE. Hoffmann P, et al. Among authors: olayioye ma. Electrophoresis. 2005 Mar;26(6):1029-37. doi: 10.1002/elps.200406197. Electrophoresis. 2005. PMID: 15704244

5

CPAP is a novel stat5-interacting cofactor that augments stat5-mediated transcriptional activity.

Peng B, Sutherland KD, Sum EY, Olayioye M, Wittlin S, Tang TK, Lindeman GJ, Visvader JE. Peng B, et al. Mol Endocrinol. 2002 Sep;16(9):2019-33. doi: 10.1210/me.2002-0108. Mol Endocrinol. 2002. PMID: 12198240

6

Threonine 391 phosphorylation of the human prolactin receptor mediates a novel interaction with 14-3-3 proteins.

Olayioye MA, Guthridge MA, Stomski FC, Lopez AF, Visvader JE, Lindeman GJ. Olayioye MA, et al. J Biol Chem. 2003 Aug 29;278(35):32929-35. doi: 10.1074/jbc.M302910200. Epub 2003 Jun 20. J Biol Chem. 2003. PMID: 12819209 Free article.

7

XIAP-deficiency leads to delayed lobuloalveolar development in the mammary gland.

Olayioye MA, Kaufmann H, Pakusch M, Vaux DL, Lindeman GJ, Visvader JE. Olayioye MA, et al. Cell Death Differ. 2005 Jan;12(1):87-90. doi: 10.1038/sj.cdd.4401524. Cell Death Differ. 2005. PMID: 15540113 No abstract available.

8

CPAP interacts with 14-3-3 in a cell cycle-dependent manner.

Chen CY, Olayioye MA, Lindeman GJ, Tang TK. Chen CY, et al. Among authors: olayioye ma. Biochem Biophys Res Commun. 2006 Apr 21;342(4):1203-10. doi: 10.1016/j.bbrc.2006.02.089. Epub 2006 Feb 24. Biochem Biophys Res Commun. 2006. PMID: 16516142

9

The GEF-H1/PKD3 signaling pathway promotes the maintenance of triple-negative breast cancer stem cells.

Lieb WS, Lungu C, Tamas R, Berreth H, Rathert P, Storz P, Olayioye MA, Hausser A. Lieb WS, et al. Among authors: olayioye ma. Int J Cancer. 2020 Jun 15;146(12):3423-3434. doi: 10.1002/ijc.32798. Epub 2019 Dec 14. Int J Cancer. 2020. PMID: 31745977 Free PMC article.

10

miR-181 elevates Akt signaling by co-targeting PHLPP2 and INPP4B phosphatases in luminal breast cancer.

Strotbek M, Schmid S, Sánchez-González I, Boerries M, Busch H, Olayioye MA. Strotbek M, et al. Among authors: olayioye ma. Int J Cancer. 2017 May 15;140(10):2310-2320. doi: 10.1002/ijc.30661. Epub 2017 Mar 11. Int J Cancer. 2017. PMID: 28224609

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

69 results

Search Page

Filters